Strategies for Overcoming Blood-Brain Barrier in Drug Development

Keywords

Blood-Brain Barrier
Drug Delivery
Nanotechnology
Brain Diseases
Drug Development
Neurotherapeutics

Abstract

The blood-brain barrier (BBB) presents a major challenge in the development of therapeutics for central nervous system (CNS) disorders. This selective permeability barrier restricts the passage of many potential drugs, limiting treatment efficacy. Overcoming the BBB is crucial for the successful delivery of neurotherapeutics, including small molecules, biologics, and gene therapies. This article explores the various strategies currently employed to bypass or modulate the BBB, such as drug delivery systems, nanotechnology, and biological agents. These methods have shown promise in improving drug bioavailability in the brain and advancing the treatment of neurodegenerative diseases, brain cancers, and other CNS conditions.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Dr. John Doe (Author)